Displaying results 26 - 26 of 26
Clear search
Healx raises $10m as investors back AI to find rare disease treatments faster
Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, has announced a $10 million Series A funding round, led by Balderton Capital, Europe’s leading early-stage venture investor. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.